Analysis in progress
Initialising…
0%
complete
This report is still being assembled — sections appear as each stage finishes. It isn't final yet.
ATRX
Final classification
Likely Benign
ATRX c.7315C>A · p.Pro2439Thr
ATRX

NM_000489.5:c.7315C>A (p.Pro2439Thr) is a missense variant in exon 35 of the ATRX gene. This variant is absent from gnomAD v2.1 and v4.1 (PM2_Supporting).

Gene
ATRX
Transcript
NM_000489.5
HGVS · transcript:coding
NM_000489.5:c.7315C>A
Consequence
N/A
GRCh38
chrX:77508515 G>T
GRCh37
chrX:76763993 G>T
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting, BP4 supporting benign, BP6 supporting benign; combination = 1 supporting + 2 supporting benign, which maps to Likely Benign.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PM2 supporting, BP4 supporting benign, BP6 supporting benign; combination = 1 supporting + 2 supporting benign, which maps to Likely Benign.
Classification rationale
PM2 BP4BP6 Likely Benign
ATRX c.7315C>A

NM_000489.5:c.7315C>A (p.Pro2439Thr) is a missense variant in exon 35 of the ATRX gene. This variant is absent from gnomAD v2.1 and v4.1 (PM2_Supporting).1 Multiple lines of computational evidence suggest no deleterious effect: BayesDel score of -0.166588 is in the benign range, and SpliceAI predicts no splicing impact (max delta = 0.00) (BP4_Supporting).2 A clinical testing laboratory (Invitae/Labcorp) has classified this variant as Likely benign in ClinVar (SCV002431510, criteria provided, single submitter) (BP6_Supporting). Caution: the ClinVar record matched to a different transcript version (NM_000489.6:c.7429C>A vs NM_000489.5:c.7315C>A), though these likely represent the same genomic variant.3 Under generic ACMG/AMP 2015 classification rules (PMID:25741868), the combination of two supporting benign criteria (BP4, BP6) meets the threshold for Likely Benign, despite one supporting pathogenic criterion (PM2).4

PM2 + BP4 + BP6 Likely Benign
2 bayesdelspliceai ↗
4 generic_acmg_combination_rules
Gene diagram · NM_000489.5 · variants mapped to exon structure
ATRX NM_000489.5
Fetching transcript structure from UCSC…
Applied criteria · 3 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency · supports benign
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      Absent from gnomAD v4.1.
      v2.1
      Absent from gnomAD v2.1.
      🇨🇦 CA
      Absent from gnomAD-Canada v1.0.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      gnomAD v2.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      gnomAD Canada 🇨🇦
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      ClinVar screenshot
      ClinVar
      Error retrieving ClinVar entry.
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00). BayesDel score = -0.166588.
      Functional / OncoKB screenshot
      Functional Unknown Oncogenic Effect
      OncoKB did not identify variant-specific reviewed functional evidence for this variant; gene-level curated context is available for reviewer follow-up. ATRX, a tumor suppressor involved in transcriptional regulation, is infrequently altered in cancer.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Sources & reference links
      8Sources
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      gnomAD-Canada
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots
      Triaged references · 2 PMIDs not cited in assessment
      20301622 ↗ Alpha-Thalassemia X-Linked Intellectual Disability Syndrome. CLINVAR
      28492532 ↗ Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. CLINVAR